Replies to post #17839 on MindMaze Therapeutics Holding (RLFTF)

[trademax42]

For the IV formulation, the company is running trials on 144 patients and its expected to complete the trials within about 3 to 4 months from the start date. For the inhaled formulation they will be having 80 participants. It shouldn't take too long to run the trials.

$RLFTF

Just my opinion, do your own dd.